GR3003880T3 - - Google Patents

Info

Publication number
GR3003880T3
GR3003880T3 GR920400302T GR920400302T GR3003880T3 GR 3003880 T3 GR3003880 T3 GR 3003880T3 GR 920400302 T GR920400302 T GR 920400302T GR 920400302 T GR920400302 T GR 920400302T GR 3003880 T3 GR3003880 T3 GR 3003880T3
Authority
GR
Greece
Prior art keywords
rheumatoid arthritis
treatment
methylpyrido
dimethoxybenzyl
diamino
Prior art date
Application number
GR920400302T
Other languages
Greek (el)
English (en)
Inventor
Carol S S Charping
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3003880T3 publication Critical patent/GR3003880T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR920400302T 1987-02-06 1992-02-25 GR3003880T3 (OSRAM)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878702758A GB8702758D0 (en) 1987-02-06 1987-02-06 Treatment of disease

Publications (1)

Publication Number Publication Date
GR3003880T3 true GR3003880T3 (OSRAM) 1993-03-16

Family

ID=10611861

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920400302T GR3003880T3 (OSRAM) 1987-02-06 1992-02-25

Country Status (11)

Country Link
US (1) US4818759A (OSRAM)
EP (1) EP0279565B1 (OSRAM)
JP (1) JP2527782B2 (OSRAM)
AT (1) ATE70977T1 (OSRAM)
AU (1) AU606128B2 (OSRAM)
CA (1) CA1302273C (OSRAM)
DE (1) DE3867251D1 (OSRAM)
ES (1) ES2039610T3 (OSRAM)
GB (1) GB8702758D0 (OSRAM)
GR (1) GR3003880T3 (OSRAM)
ZA (1) ZA88830B (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1229203B (it) * 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
PT100905A (pt) * 1991-09-30 1994-02-28 Eisai Co Ltd Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
MXPA03007166A (es) * 2001-02-12 2003-11-18 Hoffmann La Roche Pirido-pirimidinas 6-sustituidas.
EP1896035B1 (en) 2004-06-16 2014-10-15 Jack L. Arbiser Carbazole formulations for the treatment of psoriasis and angiogenesis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3322765A (en) * 1963-10-30 1967-05-30 Burroughs Wellcome Co 2, 4-diamino-6-benzylpyrido-(2, 3-d) pyrimidines and method
ZA803539B (en) * 1979-06-14 1982-01-27 Wellcome Found Alkoxybenzylrimidines method for their preparation formulation thereof and their use in medicine
IT1146940B (it) * 1979-06-14 1986-11-19 Wellcome Found Composti 2,4-diamminopirido (2,3-d) pirimidinici dotati di attivita' farmacologica e procedimento per la loro preparazione
ZA861235B (en) * 1985-03-08 1986-10-29 Univ Princeton Pyrido(2,3-d)pyrimidine derivatives
EP0278686A1 (en) * 1987-02-07 1988-08-17 The Wellcome Foundation Limited Pyridopyrimidines methods for their preparation and pharmaceutical formulations thereof
SE9801992D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl-2-hydroxypropionic acid derivative I

Also Published As

Publication number Publication date
GB8702758D0 (en) 1987-03-11
EP0279565A1 (en) 1988-08-24
AU606128B2 (en) 1991-01-31
CA1302273C (en) 1992-06-02
ES2039610T3 (es) 1993-10-01
JP2527782B2 (ja) 1996-08-28
JPS63216884A (ja) 1988-09-09
EP0279565B1 (en) 1992-01-02
ZA88830B (en) 1989-10-25
AU1135788A (en) 1988-08-11
US4818759A (en) 1989-04-04
DE3867251D1 (de) 1992-02-13
ATE70977T1 (de) 1992-01-15

Similar Documents

Publication Publication Date Title
EP0379806A3 (en) Pyrimidines and their pharmaceutical acceptable salts, and their use as medicines
EP0495982A4 (en) Bicyclic pyrimidine derivative, method of producing the same, and pharmaceutical preparation containing the same as active ingredient
FR2492382B1 (OSRAM)
MA21682A1 (fr) Procede de preparation d'agents therapeutiques derives de la quainclidine.
ZA883602B (en) Medicament
MA22894A1 (fr) Procede de preparation d'un vaccin.
ZA914135B (en) Method of treating impotence
IL90271A0 (en) Antiviral drug
FI911763A7 (fi) N5-metyyli-5,6,7,8-tetrahydrofoolihapon ammoniumsuolat
AU8091787A (en) The use of paroxetine to treat pain
DE3566404D1 (en) Substituted benzopyrans, process for their preparation and their use in medicines
GR3004440T3 (OSRAM)
AU5198693A (en) A method of increasing adenosine excretion
GR3003880T3 (OSRAM)
MY104521A (en) Treatment of depression.
EP0500953A4 (en) Antineoplastic effect potentiator and antineoplastic agent
ZA936300B (en) Use of L-carnitine and acyl L-carnitines for treating patients suffering from AIDS and AIDS-related syndromes and asymptomatic HIV-seropositive patients
FR2604707B1 (fr) Procede de preparation d'un compose therapeutique actif
HU9202103D0 (en) Method for producing inosite-phosphate analogues and pharmaceutical preparatives containing these compounds
HUT47384A (en) Insecticides and acaricides comprising pyrimidine derivatives as active ingredient and process for producing the active ingredient
FR2692261B1 (fr) Procédé de préparation d'un télogène actif.
CA2062094A1 (en) Method of treating mania